Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EntecaBell ODT vs Baraclude in Chronic Hepatitis B
NCT02588937Phase 4Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Oct 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02588937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02588937.